Core Viewpoint - Anselme Limited has increased its stake in Huakang Biomedical (08622) by acquiring 138.672 million shares at an average price of HKD 0.126 per share, totaling approximately HKD 17.4727 million, resulting in a new holding of about 259 million shares, representing 51.84% ownership [1] Group 1 - Anselme Limited's acquisition of shares occurred on October 9 [1] - The average price per share for the transaction was HKD 0.126 [1] - The total amount spent on the acquisition was approximately HKD 17.4727 million [1] Group 2 - Following the transaction, Anselme Limited's total shareholding in Huakang Biomedical increased to approximately 259 million shares [1] - The new ownership percentage after the acquisition is 51.84% [1] - The transaction involved other related parties, specifically Zhou Xun Yong [1]
Anselme Limited增持华康生物医学(08622)约1.39亿股 每股均价0.126港元